Qure.ai raises $65 million in funding in Sequence B funding spherical
Indian healthcare know-how firm Qure.ai has raised $65 million in a Sequence D funding spherical to fund its enlargement into the US and different areas.
The corporate may also use the funding to put money into its foundational AI fashions and purchase complementary medical know-how corporations.
Lightspeed and 360One Asset led the financing spherical, which additionally included new strategic and monetary buyers akin to Merck International Well being Innovation Fund and Kae Capital.
Current buyers akin to Novo Holdings, Well being Quad and TeamFund additionally contributed to the spherical.
Based in 2016, Qure.ai focuses on making healthcare extra accessible and equitable worldwide.
The corporate's AI options are at present utilized in greater than 3,000 places in additional than 90 nations for the identification and administration of vital illnesses.
Acquire entry to probably the most complete firm profiles in the marketplace, powered by GlobalData. Save hours of analysis. Acquire aggressive benefit.
Firm Profile – Free Pattern
Your obtain e mail will arrive shortly
We have now confidence within the distinctive high quality of our firm profiles. Nonetheless, we would like you to take advantage of helpful determination for what you are promoting. That's why we give you a free pattern you can obtain by submitting the shape beneath.
By GlobalData
Qure.ai at present has 18 indications authorised by the US Meals and Drug Administration (FDA), whereas its merchandise are licensed as Class IIb beneath the EU's Medical Machine Regulation (MDR).
Prashant Warier, co-founder and CEO of Qure.ai, stated: “Qure.ai has grow to be a trusted AI medical imaging associate for hospitals and healthcare organizations all over the world.
“Our work contributes to unlocking medical efficiencies and enhancing the standard of take care of sufferers within the focus areas of tuberculosis, lung most cancers and stroke.
“AI helps to beat healthcare bottlenecks, from imaging reporting backlogs and low screening charges to restricted workforce assets, not solely in Western societies just like the US and Europe, but in addition in growing nations.
“We’re additionally working with half of the highest 20 pharmaceutical and medical know-how corporations, together with AstraZeneca, Medtronic and J&J, to speed up the early prognosis and well timed remedy of illnesses.”
Final yr, Qure.ai and AI platform supplier Blackford collaborated to implement an AI-driven neurocritical answer at Milton Keynes College Hospital NHS Basis Belief.
